Secukinumab is effective in subjects with moderate to severe palmoplantar psoriasis: 1.5 year results from the GESTURE study

Authors
Category Primary study
JournalJournal of Clinical and Aesthetic Dermatology
Year 2017
This article has no abstract
Epistemonikos ID: 54a014ee0dc81d00187100db8bf9ff3cd210d676
First added on: Feb 09, 2025